EP Patent

EP0320550A1 — Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent

Assigned to Bristol Myers Co · Expires 1989-06-21 · 37y expired

What this patent protects

A nonsteroidal anti-inflammatory drug composition containing as protectants against gastrointestinal injury, H₁ blockers, H₂ blockers, beta-adrenergic agonists, or combinations thereof, and an alkalizing agent and a process for administering such compositions.

USPTO Abstract

A nonsteroidal anti-inflammatory drug composition containing as protectants against gastrointestinal injury, H₁ blockers, H₂ blockers, beta-adrenergic agonists, or combinations thereof, and an alkalizing agent and a process for administering such compositions.

Drugs covered by this patent

Patent Metadata

Patent number
EP0320550A1
Jurisdiction
EP
Classification
—
Expires
1989-06-21
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.